CIK 0001651308 · Large accelerated filer
BeOne Medicines Ltd.
Sign in to watch- Ticker
- BEIGF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981209416
- Phone
- 41-616851900
- Business address
- C/O BEONE MEDICINES I GMBH, AESCHENGRABEN 27, 21ST FLOOR, BASEL, Switzerland, 4051
- Former names
- BeiGene, Ltd.
Securities
- ONC American Depositary Shares Nasdaq
- BEIGF Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $48,487,541
- in 9 filings, $47.8M under 10b5-1 plans
Net −$48,487,541. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Option exercise | +40,109 | $6.50 | $261K | 40,109 |
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Sale | −3,500 | $256.91 | $899K | 36,609 |
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Sale | −13,598 | $257.92 | $3.5M | 23,011 |
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Sale | −8,200 | $258.91 | $2.1M | 14,811 |
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Sale | −6,705 | $259.77 | $1.7M | 8,106 |
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Sale | −2,906 | $261.08 | $759K | 5,200 |
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Sale | −3,400 | $262.03 | $891K | 1,800 |
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Sale | −1,700 | $262.97 | $447K | 100 |
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Sale | −100 | $264.27 | $26K | 0 |
| 2025-03-06 | OYLER JOHN Chief Executive Officer | Option exercise · Share Option (Right to Buy) | −1,007,578 | 6,559,391 | ||
| 2025-03-05 | OYLER JOHN Chief Executive Officer | Grant or award | +201,084 | 4,405,895 | ||
| 2025-03-05 | Wu Xiaobin President, COO & GM China | Grant or award 10b5-1 | +103,883 | 1,175,210 | ||
| 2025-03-05 | Wu Xiaobin President, COO & GM China | Option exercise 10b5-1 | +7,048 | $169.65 | $1.2M | 7,048 |
| 2025-03-05 | Wu Xiaobin President, COO & GM China | Option exercise 10b5-1 | +44,873 | $119.96 | $5.4M | 51,921 |
| 2025-03-05 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −17,824 | $260.39 | $4.6M | 34,097 |
| 2025-03-05 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −11,360 | $261.61 | $3.0M | 22,737 |
| 2025-03-05 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −22,537 | $262.51 | $5.9M | 200 |
| 2025-03-05 | Wu Xiaobin President, COO & GM China | Sale 10b5-1 | −200 | $263.00 | $53K | 0 |
| 2025-03-05 | Wu Xiaobin President, COO & GM China | Option exercise · Share Option (Right to Buy) 10b5-1 | −91,624 | 2 | ||
| 2025-03-05 | Wu Xiaobin President, COO & GM China | Option exercise · Share Option (Right to Buy) 10b5-1 | −583,349 | 214,201 |
Page 30 of 71 · 1,406 trades